Antoine Italiano
MD, PhD
Head, Drug Development Unit
👥Biography 个人简介
Dr. Antoine Italiano is a French medical oncologist and drug development specialist who has contributed to the early-phase evaluation of tarlatamab, the DLL3 x CD3 bispecific T-cell engager, in small cell lung cancer. His drug development unit has participated in Phase I/II tarlatamab trials and he has contributed to characterizing DLL3 expression as a biomarker for therapeutic selection. He is a leading voice in European early-phase oncology clinical trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Antoine Italiano 的研究动态
Follow Antoine Italiano's research updates
留下邮箱，当我们发布与 Antoine Italiano（Institut Bergonie）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment